Antman KH - Search Results

1

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH. Talbot SM, et al. Among authors: antman kh. Cancer. 2003 Jul 15;98(2):331-6. doi: 10.1002/cncr.11512. Cancer. 2003. PMID: 12872353 Free article. Clinical Trial.

2

A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.

Antman K, Crowley J, Balcerzak SP, Kempf RA, Weiss RB, Clamon GH, Baker LH. Antman K, et al. Cancer. 1998 Apr 1;82(7):1288-95. Cancer. 1998. PMID: 9529020 Clinical Trial.

3

Chemotherapy for malignant mesothelioma.

Taub RN, Antman KH. Taub RN, et al. Among authors: antman kh. Semin Thorac Cardiovasc Surg. 1997 Oct;9(4):361-6. Semin Thorac Cardiovasc Surg. 1997. PMID: 9352953 Review.

4

Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.

Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. Zalupski MM, et al. Cancer. 2004 Feb 15;100(4):818-25. doi: 10.1002/cncr.20021. Cancer. 2004. PMID: 14770440 Free article. Clinical Trial.

5

A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.

Tiersten AD, Nelsen C, Talbot S, Vahdat L, Fine R, Troxel A, Brafman L, Shriberg L, Antman K, Petrylak DP. Tiersten AD, et al. Cancer. 2003 Feb 1;97(3):537-44. doi: 10.1002/cncr.11082. Cancer. 2003. PMID: 12548594 Free article. Clinical Trial.

6

A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma.

Keohan ML, Grever MR, Balcerzak SP, Antman K. Keohan ML, et al. Invest New Drugs. 1997;15(3):255-6. doi: 10.1023/a:1005803921371. Invest New Drugs. 1997. PMID: 9387048 Clinical Trial.

7

Incidence of malignant pleural mesothelioma after thoracic radiotherapy.

Neugut AI, Ahsan H, Antman KH. Neugut AI, et al. Among authors: antman kh. Cancer. 1997 Sep 1;80(5):948-50. doi: 10.1002/(sici)1097-0142(19970901)80:5<948::aid-cncr17>3.0.co;2-w. Cancer. 1997. PMID: 9307196

8

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL, et al. Antman K, et al. J Clin Oncol. 1993 Jul;11(7):1276-85. doi: 10.1200/JCO.1993.11.7.1276. J Clin Oncol. 1993. PMID: 8315425 Clinical Trial.

9

Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.

Budd GT, Rankin C, Hutchins LF, Wong L, Petruska PJ, Antman K; Southwest Oncology Group. Budd GT, et al. Invest New Drugs. 2002 Feb;20(1):129-32. doi: 10.1023/a:1014461611890. Invest New Drugs. 2002. PMID: 12003189 Clinical Trial.

10

Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.

Yogelzang NJ, Herndon JE 2nd, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR. Yogelzang NJ, et al. Among authors: antman kh. Cancer. 1997 Jun 1;79(11):2237-42. doi: 10.1002/(sici)1097-0142(19970601)79:11<2237::aid-cncr23>3.0.co;2-w. Cancer. 1997. PMID: 9179072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters